For: | Xu GQ, Xu CF, Chen HT, Liu S, Teng XD, Xu GY, Yu CH. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice. World J Gastroenterol 2014; 20(28): 9513-9518 [PMID: 25071346 DOI: 10.3748/wjg.v20.i28.9513] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i28/9513.htm |
Number | Citing Articles |
1 |
Guanghui Chen, Qi Zhang, Can Ai, Songqiang Huang, Huizhen Zhang, Xiaoyu Guo, Wenju Wang, Weiying Hua, Huichang Bi, Hui Wang. Serum metabolic profile characteristics of offspring rats before and after birth caused by prenatal caffeine exposure. Toxicology 2019; 427: 152302 doi: 10.1016/j.tox.2019.152302
|
2 |
Chang Yin, Ruqing Zhong, Weidong Zhang, Lei Liu, Liang Chen, Hongfu Zhang. The Potential of Bile Acids as Biomarkers for Metabolic Disorders. International Journal of Molecular Sciences 2023; 24(15): 12123 doi: 10.3390/ijms241512123
|
3 |
Rafiq A. Shahid, David Q.‐H. Wang, Brian E. Fee, Shannon J. McCall, Joelle M.‐J. Romac, Steven R. Vigna, Rodger A. Liddle. Endogenous elevation of plasma cholecystokinin does not prevent gallstones. European Journal of Clinical Investigation 2015; 45(3): 237 doi: 10.1111/eci.12400
|
4 |
Jun Chang, Yan Liu, Ting-Can Jiang, Lan Zhao, Jian-Wei Liu. Cholecystokinin and cholecystokinin-A receptor: An attractive treatment strategy for biliary dyskinesia?. World Journal of Gastroenterology 2024; 30(3): 283-285 doi: 10.3748/wjg.v30.i3.283
Abstract(586) |
Core Tip(575) |
Full Article(HTML)(1492)
|
Full Article with Cover (PDF)-5312K(116)
|
Full Article (Word)-106K(26)
|
Audio-1507K(6)
|
Peer-Review Report-187K(75)
|
Answering Reviewers-47K(66)
|
Full Article (PDF)-336K(132)
|
Full Article (XML)-26K(79)
|
Times Cited (0)
|
Total Visits (4254)
|
Open
|
5 |
Hasan Raza Kazmi, Abhijit Chandra, Jaya Nigam, Kavita Baghel, Meenu Srivastava, Shailendra S. Maurya, Devendra Parmar. Polymorphism and Expression Profile of Cholecystokinin Type A Receptor in Relation to Gallstone Disease Susceptibility. Biochemical Genetics 2016; 54(5): 665 doi: 10.1007/s10528-016-9745-x
|
6 |
Changlin Qian, Weiqing Qiu, Jie Zhang, Zhiyong Shen, Hua Liu, Yongjie Zhang. The long non-coding RNA MEG3 plays critical roles in the pathogenesis of cholesterol gallstone. PeerJ 2021; 9: e10803 doi: 10.7717/peerj.10803
|
7 |
Ibrahim Guillermo Castro-Torres, René de Jesús Cárdenas-Vázquez, Claudia Velázquez-González, Rosa Ventura-Martínez, Minarda De la O-Arciniega, Elia Brosla Naranjo-Rodríguez, Mariano Martínez-Vázquez. Future therapeutic targets for the treatment and prevention of cholesterol gallstones. European Journal of Pharmacology 2015; 765: 366 doi: 10.1016/j.ejphar.2015.08.045
|
8 |
Lei Huang, Chao Ding, Xinmin Si. Changes in the interstitial cells of Cajal in the gallbladder of guinea pigs fed a lithogenic diet. Experimental and Therapeutic Medicine 2021; 22(2) doi: 10.3892/etm.2021.10255
|
9 |
Guoqiang Xu, Yiqiao Li, Xin Jiang, Hongtan Chen. CAV1 Prevents Gallbladder Cholesterol Crystallization by Regulating Biosynthesis and Transport of Bile Salts. Journal of Cellular Biochemistry 2016; 117(9): 2118 doi: 10.1002/jcb.25518
|
10 |
Fang Chen, Run Guo, Tian Chen, Liping Liu, Fan Ding, Gang Zhao, Bo Zhang. The Therapeutic Potential of Low-Intensity Pulsed Ultrasound in Enhancing Gallbladder Function and Reducing Inflammation in Cholesterol Gallstone Disease. Bioengineering 2025; 12(1): 34 doi: 10.3390/bioengineering12010034
|
11 |
Marlein Miranda Cona, Yewei Liu, Ting Yin, Yuanbo Feng, Feng Chen, Stefaan Mulier, Yue Li, Jian Zhang, Raymond Oyen, Yicheng Ni. Rat model of cholelithiasis with human gallstones implanted in cholestasis-induced virtual gallbladder. World Journal of Methodology 2016; 6(2): 154-162 doi: 10.5662/wjm.v6.i2.154
|